PTHS Pelthos Therapeutics Inc.

AMEX
$7.15

Pelthos Therapeutics Inc. (PTHS) Earnings News

Earnings press releases, previews and reviews for Pelthos Therapeutics Inc. (PTHS), newest first. Our most recent is review: Pelthos Misses as Zelsuvmi Stalls Sequentially, and the Castle Creek Pivot Raises the Stakes for a Balance Sheet Already Under Strain.